Clinical practice: Pulmonary hypertension in children

European Journal of Pediatrics

Volumn 168, Issue 5, 2009, Pages 515-522

  De Wolf, Daniel ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Bosentan; Children; Congenital heart disease; Pulmonary hypertension; Sildenafil; Treatment

Indexed keywords

BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; ENDOTHELIN RECEPTOR ANTAGONIST; INFLUENZA VACCINE; NIFEDIPINE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; PROSTACYCLIN; PROSTANOID; PSEUDOEPHEDRINE; SILDENAFIL; VASODILATOR AGENT;

CHILD CARE; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; CONGENITAL DISORDER; DISEASE COURSE; DRUG DOSE INCREASE; DRUG HALF LIFE; EISENMENGER COMPLEX; EPISTAXIS; EXERCISE; FLUSHING; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; IDIOPATHIC DISEASE; LUNG HEMODYNAMICS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; SIDE EFFECT; SURVIVAL RATE;

ACTIVIN RECEPTORS, TYPE II; ANTIGENS, CD; ANTIHYPERTENSIVE AGENTS; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; CALCIUM CHANNEL BLOCKERS; CHILD; ELECTROCARDIOGRAPHY; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION, PULMONARY; INCIDENCE; PIPERAZINES; POINT MUTATION; PREVALENCE; PURINES; RECEPTORS, CELL SURFACE; SULFONAMIDES; SULFONES; VASODILATOR AGENTS;

EID: 62949151255     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-008-0920-x     Document Type: Review

References (33)

1. W Avila M Grinberg R Snitcowsky 1995 Maternal and fetal outcome in pregnant women with Eisenmenger's syndrome Eur Heart J 16 460 464
2. M Beghetti M Hoeper D Kiely 2008 Safety experience with bosentan in 146 children 2-11 years old with pulmonary arterial hypertension: results from the European Postmarketing Surveillance program Pediatr Res 64 200 204
3. MM Boucek P Aurora LB Edwards 2007 Registry of the International Society for Heart and Lung Transplantation: tenth official pediatric heart transplantation report J Heart Lung Transplant 26 796 807
4. E Chau K Fan W Chow 2007 Effects of chronic sildenafil in patients with Eisenmenger syndrome versus idiopathic pulmonary arterial hypertension Int J Cardiol 120 301 305
5. G D'Alonzo R Barst S Ayres 1991 Survival in patients with primary pulmonary hypertension: results from a national prospective registry Ann Intern Med 115 343 349
6. L Daliento J Somerville P Presbitero 1998 Eisenmenger syndrome: factors relating to deterioration and death Eur Heart J 19 1845 1855
7. GP Diller M Gatzoulis 2007 Pulmonary vascular disease in adults with congenital heart disease Circulation 115 1039 1050
8. GP Diller K Dimopoulos C Broberg 2006 Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study Eur Heart J 27 1737 1742
9. M Duffels P Engelfriet R Berger 2007 Pulmonary arterial hypertension in congenital heart disease/an epidemiologic perspective from a Dutch registry Int J Cardiol 120 198 204
10. M Fasnacht J Tolsa M Beghetti 2007 The Swiss registry for pulmonary arterial hypertension: the paediatric experience Swiss Med Wkly 137 510 513
11. N Galie M Beghetti M Gatzoulis 2006 Bosentan therapy in patients with Eisenmenger syndrome/a multicenter, double-blind, randomised, placebo-controlled study Circulation 114 48 54
12. N Galie H Ghofrani A Torbicki 2005 Sildenafil citrate therapy for pulmonary arterial hypertension N Engl J Med 353 2148 2157
13. N Galie A Manes M Palazzini 2008 Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome Drugs 68 1049 1066
14. R Harrison R Berger S Haworth 2005 Transforming growth factor-beta receptor mutations and pulmonary hypertension in childhood Circulation 111 435 441
15. SG Haworth 2008 The management of pulmonary hypertension in children Arch Dis Child 93 620 625
16. M Humbert O Sitbon A Chaouat 2006 Pulmonary Arterial Hypertension in France. Results from a National Registry Am J Respir Crit Care Med 173 1023 1030
17. T Humpl J Reyes H Holtby 2005 Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study Circulation 111 3274 3280
18. S Maiya A Hislop Y Flynn 2006 Response to bosentan in children with pulmonary hypertension Heart 92 664 670
19. S Mathai R Girgis M Fisher 2007 Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension Eur Respir J 29 469 475
20. VV McLaughlin M McGoon 2006 Pulmonary arterial hypertension Circulation 114 1417 1431
21. A Peacock N Murphy J McMurray 2007 An epidemiological study of pulmonary arterial hypertension Eur Respir J 30 104 109
22. J Perloff E Hart M Greaves 2003 Proximal pulmonary arterial and intrapulmonary radiologic features of Eisenmenger syndrome and primary pulmonary hypertension Am J Cardiol 92 182 187
23. R Raymond A Hinderliter P Willis 2002 Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension J Am Coll Cardiol 39 1214 1219
24. S Rich D Dantzker S Ayres 1987 Primary pulmonary hypertension: a national prospective study Ann Intern Med 107 216 223
25. K Roberts J McElroy W Wong 2004 BMPR2 mutations in pulmonary hypertension with congenital heart disease Eur Resp J 24 371 374
26. E Rosenzweig D Ivy A Widlitz 2005 Effects of long-term bosentan in children with pulmonary arterial hypertension J Am Coll Cardiol 46 697 704
27. E Rosenzweig D Kerstein R Barst 1999 Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects Circulation 99 1858 1865
28. L Rubin D Badesch R Barst 2002 Bosentan therapy for pulmonary arterial hypertension N Engl J Med 346 896 903
29. G Simonneau N Galiè L Rubin 2004 Clinical classification of pulmonary hypertension J Am Coll Cardiol 43 suppl 1 S5 S12
30. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology 2004 ESC guidelines. Guidelines on diagnosis and treatment of pulmonary arterial hypertension Eur Heart J 25 24 2243 2278
31. R van Loon E Hoendermis M Duffels 2007 Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist? Am Heart J 154 776 782
32. J Yuan L Rubin 2005 Pathogenesis of pulmonary arterial hypertension: the need for multiple hits Circulation 111 534 538
33. D Yung A Widlitz E Rosenzweig 2004 Outcomes in children with idiopathic pulmonary arterial hypertension Circulation 110 660 665